期刊文献+

三黄三草退黄汤合熊去氧胆酸胶囊治疗慢性乙型肝炎残留性黄疸的临床研究 被引量:5

Clinical study of Sanhuang Sancao Tuihuang decoction combined with ursodeoxycholic acid capsules in the treatment of residual jaundice of chronic hepatitis B
下载PDF
导出
摘要 目的:探讨三黄三草退黄汤合熊去氧胆酸胶囊治疗慢性乙型肝炎残留性黄疸的临床疗效。方法:收治残留性黄疸患者80例,随机分为观察组和对照组。对照组采用保肝退黄基础治疗,观察组在对照组基础上加用熊去氧胆酸胶囊合三黄三草退黄汤,比较两组治疗效果。结果:观察组肝功能指标明显优于对照组(P<0.05)。结论:三黄三草退黄汤合熊去氧胆酸胶囊治疗慢性乙型肝炎残留性黄疸的临床疗效显著。 Objective:To explore the clinical effect of Sanhuang Sancao Tuihuang decoction combined with ursodeoxycholic acid capsules in the treatment of residual jaundice of chronic hepatitis B.Methods:80patients with residual jaundice were selected.They were randomly divided into the observation group and the control group.The control group was treated with basic treatment of liver protection and removing jaundice,and the observation group added Sanhuang Sancao Tuihuang decoction combined with ursodeoxycholic acid capsules on the basis of the control group.We compared the therapeutic effect of two groups.Results:The liver function indexes of the observation group were obviously better than the control group(P<0.05).Conclusion:The clinical effect of Sanhuang Sancao Tuihuang decoction combined with ursodeoxycholic acid capsules in the treatment of residual jaundice of chronic hepatitis B was significant.
作者 费秀昆 吕霄芳 温贻芳 Fei Xiukun;Lv Xiaofang;Wen Yifang(Infectious Diseases Department,the Maternal and Child Health Hospital of Zaozhuang City 277100;Hepatology Department,the Fourth Affiliated Hospital of Beijing University of Chinese Medicine,the Traditional Chinese Medicine Hospital of Zaozhuang City 277100;Hepatology Department,the Sixth People's Hospital of Xinjiang Autonomous Region 830000)
出处 《中国社区医师》 2017年第25期88-89,共2页 Chinese Community Doctors
关键词 三黄三草退黄汤 熊去氧胆酸胶囊 慢性乙型肝炎残留性黄疸 Sanhuang Sancao Tuihuang decoction Ursodeoxycholic acid capsules Residual jaundice of chronic hepatitis B
  • 相关文献

参考文献2

二级参考文献41

  • 1TRPO C,CHAN HLY,LOK A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063.
  • 2LOZANO R,NAGHAVI M,FOREMAN K,et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2013,380(9859):2095-2128.
  • 3WANG FS,FAN JG,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.
  • 4ZARSKI JP,MARCELLIN P,LEROY V,et al.Characteristics of patients with chronic hepatitis B in France:predominant frequency of HBe antigen negative cases[J].J Hepatol,2006,45(3):355-360.
  • 5YAN H,ZHONG G,XU G,et al.Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J].Elife,2012,3(1):e00049.
  • 6EZZIKOURI S,OZAWA M,KOHARA M,et al.Recent insights into hepatitis B virus-host interactions[J].J Med Virol,2014,86(6):925-932.
  • 7LOCARNINI S.Molecular virology and the development of resistant mutants:implications for therapy[C].Semin Liver Dis,2004,25:9-19.
  • 8CHENG PN,LIU WC,TSAI HW,et al.Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents[J].J Med Virol,2011,83(4):602-607.
  • 9MILICH D,LIANG TJ.Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection[J].Hepatology,2003,38(5):1075-1086.
  • 10BENHENDA S,COUGOT D,BUENDIA MA,et al.Hepatitis B virus X protein:molecular functions and its role in virus life cycle and pathogenesis[J].Adv Cancer Res,2009,103:75-109.

共引文献15

同被引文献43

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部